Insiders Trades
Ambu A/S Stock: price and insider trades · Denmark
No insider purchase over the last 90 days. The latest was filed 09 Jun 2026.
Ambu A/S: what insiders have been doing
Ambu A/S, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finanstilsynet DK. The last twelve months, up to 18 October 2026, brought 6 filings signed by 6 insiders.
Every open-market trade in the period is a purchase: 1 purchase worth €24k, from 1 insider, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €24k, bought by Britt Meelby Jensen and made public on 9 June 2026 (0.0009% of market cap). Among those who bought: 1 chief executive.
With 6 filings in twelve months, the company is more active than the median of 4 filings across the 74 companies we follow on the same exchange. Since 2005, the database holds 13 purchases and 2 sales by insiders of the company.
The most recent open-market purchase was published on 9 June 2026, 130 days ago. Most trades are made public on the day they happen. Under the Market Abuse Regulation, managers have three business days to notify their trades.
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from Finanstilsynet DK. Past trades are no guide to future returns.
Insider Decl.
228
Thresholds
n/a
Buy Volume
€6M
13 ops. · all time
Sell Volume
€385M
2 ops. · all time
Who traded when
BuySaleUnknown2 buys
Britt Meelby Jensen1 buy
Analyst consensus: bullish or bearish?
Analysts rate Ambu A/S Hold (neutral), based on 7 analysts. Average price target: DKK 81.77.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,535 of 24,148 companies
52.7
score / 100
Value40
Quality65
FCF yld2.9%
Earn yld1.3%
EV/EBITDA18.2x
ROE8.4%
Gross mgn59%
Net mgn4.4%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended September 2024 · cache
DKK 69.45
Analyst consensus
7 analystsHold
DKK 61.00Target DKK 81.77(+18%)DKK 116.40
Income statement
RevenueDKK 5.4B
Gross profitDKK 3.2B59% margin
EBITDADKK 1B19% margin
Net incomeDKK 235M8.2% margin
Valuation
PER (trailing)36.6x
PER (forward)22.9x
P/Book3.0x
Beta1.38
Balance sheet & cash
Market capDKK 18.1B
Total debtDKK 558M
Free Cash FlowDKK 524M
Debt / Equity9%
Profitability & ownership
ROE8.4%
ROA5.8%
% insiders0.0%
% institutions27.7%
Last declaration on 9 June 2026
Declarations228 total
2,670.06 shares@ DKK 66.520.0009% mcap100.0% of flowShareOutside a trading venueISIN DK0060946788DK:1447108
Canonical exit: 30 Aug 2026 (T+90)
ShareDK:1446504
ShareDK:1440637
ShareDK:1411891
ShareDK:1399715
ShareDK:1399503
3 shares@ DKK 15.000.0000% mcap0.0% of flowShareOther OTCISIN DK0060946788DK:1363832
Canonical exit: 14 Aug 2025 (T+90)
ShareDK:1362835
ShareDK:1331427
7,500 shares@ DKK 114.090.0043% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060946788DK:1329466
Canonical exit: 20 Feb 2025 (T+90)
ShareDK:1329465
ShareDK:1326558
12,500 shares@ DKK 118.560.0074% mcap0.1% of flowShareNasdaq CopenhagenISIN DK0060946788DK:1274021
Canonical exit: 9 May 2024 (T+90)
40,564 shares0ShareOutside trading venueISIN DK0060946788DK:1240445
1,400 shares@ DKK 83.060.0006% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060946788DK:1194499
Canonical exit: 27 Feb 2023 (T+90)
41,333 shares@ DKK 73.100.015% mcap0.1% of flowShareNasdaq CopenhagenISIN DK0060946788DK:1178117
Canonical exit: 27 Nov 2022 (T+90)
5,000 shares@ DKK 198.500.0050% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060946788DK:1127474
137,600 shares@ DKK 188.770.9% of flowShareNasdaq CopenhagenISIN DK0060946788DK:1112603
Canonical exit: 28 Nov 2021 (T+90)
328 shares@ DKK 235.810.0% of flowShareOutside a trading venue (shares received after vesting will be listed onISIN DK0060946788DK:1034032
Canonical exit: 24 Aug 2021 (T+90)
625 shares@ DKK 235.810.0% of flowShareOutside a trading venue (shares received after vesting will be listed onISIN DK0060946788DK:1034030
Canonical exit: 24 Aug 2021 (T+90)
4,358 shares@ DKK 229.040.0% of flowShareNasdaq Copenhagen XCSEISIN DK0060946788DK:1034028
Canonical exit: 25 Aug 2021 (T+90)
7,254 shares0ShareOutside a trading venueISIN DK0060946788DK:1002241
25,951 shares0ShareOutside a trading venueISIN DK0060946788DK:1002239
10,017 shares@ DKK 200.210.1% of flowShareNasdaq CopenhagenISIN DK0060946788DK:976599
Canonical exit: 9 Mar 2021 (T+90)
39,000 shares@ DKK 190.080.3% of flowShareNasdaq CopenhagenISIN DK0060946788DK:976293
Canonical exit: 7 Mar 2021 (T+90)
25 of 228 declarations
About Ambu A/S
Ambu A/S is a Danish company that specializes in the development and manufacturing of medical devices. It primarily focuses on products for resuscitation, anesthesia, and patient monitoring.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
